Adherence, Determinants and Barriers to Calcium Supplementation in Pregnancy: A Mixed Methods Study
Keywords:
Adherence, Antenatal, Calcium, Pre-ecclampsia, SupportAbstract
Background: Calcium intake of 1gram/day in pregnancy reduces the risk of pre-ecclampsia and preterm birth. Universal free calcium supplementation program was started throughout India at considerable cost to the government. Although coverage is high, this program is only effective if there is good adherence among mothers, and this is unknown. This study was conducted to estimate the prevalence of adherence to calcium tablets among mothers and to identify the determinants and barriers to adherence to calcium supplementation. Methods: A cross sectional mixed methods study was conducted among mothers attending antenatal clinic at Kundrathur PHC. Mothers with >20 weeks of gestation were recruited consecutively. They were interviewed using the Morisky Medication Adherence Scale (MMAS-8). Barriers to adherence were elicited by freelisting and analysed using Visual Anthropac 1.0. Results: 89 mothers completed the study. The participants had a mean age of 25.29+4.275 years. Majority of mothers were literate and primi gravida. The Mean MMAS score was 4.98+1.79 (95% CI 4.61, 5.36), out of a maximum score of 8. In our study, the majority of mothers (69.66%, 95%CI 59, 78.97) had low adherence, and high adherence was seen only in 6.7% women. (95% CI 2.51, 14.10). Only 3.4% mothers were aware of the role of calcium in hypertension. There was a significant association between adherence and level of education, and having a support person (OR 11.5, 95%CI -2.568, 51.502). Major barriers identified were forgetfulness, big size of the tablet, vomiting, dosing schedule and unavailability of tablets. Conclusion: Adherence to Calcium supplementation is low among mothers. Having a designated support partner in pregnancy, who helps in reminding and giving supplements, can help improve adherence. Addressing the major barriers identified can help in improving adherence and reducing hypertension in pregnancy.
Downloads
References
1. WHO recommendations for prevention and treatment of pre- eclampsia and eclampsia. Available from: https://www.who.int/publications/i/item/9789241548335
2. Maternal Health Division, Ministry of Health and Family Welfare, Government of India. National guidelines for calcium supplementation during pregnancy and lactation; 2014. Available from: https://nhmodisha.gov.in/writereaddata/Upload/Documents/National_Guidelines_for_Calcium_Supplementa…
3. IAPSM | Indian Association of Preventive and Social Medicine. Available from: https://www.iapsm.org/maternal-health.html
4. Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Look PFV. WHO analysis of causes of maternal death: A systematic review. The Lancet. 2006; 367(9516): 1066- 74. https://doi.org/10.1016/S0140- 6736(06)68397-9 PMid: 16581405.
5. World Health Organization. WHO recommendation: calcium supplementation during pregnancy for prevention of pre- eclampsia and its complications. Geneva: World Health Organization; 2018. p. 44. Available from: https://iris.who.int/handle/10665/277235
6. Dhinwa M, Gawande K, Jha N, Anjali M, Bhadoria AS, Sinha S. Prevalence of hypertensive disorders of pregnancy in India: A systematic review and meta- analysis. J Med Evid. 2021; 2(2): 105. https://doi.org/10.4103/JME.JME_168_20
7. Li F, Wang T, Chen L, Zhang S, Chen L, Qin J. Adverse pregnancy outcomes among mothers with hypertensive disorders in pregnancy: A meta- analysis of cohort studies. Pregnancy Hypertens. 2021; 24: 107- 17. https://doi.org/10.1016/j.preghy.2021.03.001 PMid: 33813363.
8. Perin J, Mulick A, Yeung D, Villavicencio F, Lopez G, Strong KL, et al. Global, regional, and national causes of under5 mortality in 2000- 19: An updated systematic analysis with implications for the Sustainable Development Goals. Lancet Child Adolesc Health. 2022; 6(2): 106- 15. https://doi.org/10.1016/S2352-4642(21)00311-4 PMid: 34800370.
9. Hofmeyr GJ, Lawrie TA, Atallah ÁN, Torloni MR. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev. 2018; 2018(10): CD001059. https://doi.org/10.1002/14651858.CD001059.pub5 PMid: 30277579.
10. Imdad A, Bhutta ZA. Effects of calcium supplementation during pregnancy on maternal, fetal and birth outcomes. Paediatr Perinat Epidemiol. 2012; 26 Suppl 1: 138- 52. https://doi.org/10.1111/j.1365-3016.2012.01274.x PMid: 22742607.
11. Harinarayan CV, Akhila H, Shanthisree E. Modern India and dietary calcium deficiency- half a century nutrition data- retrospect- introspect and the road ahead. Front Endocrinol. 2021; 12: 583654. https://doi.org/10.3389/fendo.2021.583654 PMid: 33889131 PMCid: PMC8056136.
12. Bora K, Barman B, Pala S, Das A, Doke G, Tripura A. Coverage of antenatal iron- folic acid and calcium distribution during pregnancy and their contextual determinants in the northeastern region of India. Front Nutr. 2022; 9: 894245. https://doi.org/10.3389/fnut.2022.894245 PMid: 35923196 PMCid: PMC9339897.
13. Shakya Shrestha S, Adhikari R, Tamrakar SR, Shrestha R, Shrestha A. Adherence to Iron, folic acid and calcium supplement and factors affecting it among the antenatal care attending women in a tertiary care hospital: A cross sectional study. Kathmandu Univ Med J. 2020; 18: 83- 90. https://doi.org/10.3126/kumj.v18i2.33265
14. Liu D, Cheng Y, Dang S, Wang D, Zhao Y, Li C, et al. Maternal adherence to micronutrient supplementation before and during pregnancy in Northwest China: Alargescale population- based cross- sectional survey. BMJ Open. 2019; 9(8): e028843. https://doi.org/10.1136/bmjopen2018-028843 PMid: 31399455 PMCid: PMC6701669.
15. Ajong AB, Kenfack B, Ali IM, Yakum MN, Ukaogo PO, Mangala FN, et al. Calcium supplementation in pregnancy: An analysis of potential determinants in an under- resourced setting. Plos One. 2023; 18(10): e0292303. https://doi.org/10.1371/journal.pone.0292303 PMid: 37796953 PMCid: PMC10553325.
16. Cormick G, Moraa H, Zahroh RI, Allotey J, Rocha T, Peña- Rosas JP, et al. Factors affecting the implementation of calcium supplementation strategies during pregnancy to prevent pre- eclampsia: A mixed- methods systematic review. BMJ Open. 2023; 13(12): e070677. https://doi.org/10.1136/bmjopen-2022-070677 PMid: 38135336 PMCid: PMC10749021.
17. Martin SL, Wawire V, Ombunda H, Li T, Sklar K, Tzehaie H, et al. Integrating calcium supplementation into facilitybased antenatal care services in Western Kenya: A qualitative process evaluation to identify implementation barriers and facilitators. Curr Dev Nutr. 2018; 2(11): nzy068. https://doi.org/10.1093/cdn/nzy068 PMid: 30402593 PMCid: PMC6215767.
18. International Institute for Population Sciences (IIPS) and ICF. National Family Health Survey (NFHS- 5), India, 201921: Tamil Nadu. Mumbai: IIPS; 2021.
19. Dwarkanath P, Muhihi A, Sudfeld CR, Wylie BJ, Wang M, Perumal N, et al. Two Randomized trials of low- dose calcium supplementation in pregnancy. N Engl J Med. 2024; 390(2): 143- 53. https://doi.org/10.1056/NEJMoa2307212 PMid: 38197817 PMCid: PMC10921922.
20. Omotayo MO, Dickin KL, Pelletier DL, Mwanga EO, Kung’u JK, Stoltzfus RJ. A simplified regimen compared with WHO guidelines decreases antenatal calcium supplement intake for prevention of preeclampsia in a cluster- randomized noninferiority trial in rural Kenya. J Nutr. 2017; 147(10): 1986- 91. https://doi.org/10.3945/jn.117.251926 PMid: 28878035.
21. Martin SL, Omotayo MO, Chapleau GM, Stoltzfus RJ, Birhanu Z, Ortolano SE, et al. Adherence partners are an acceptable behaviour change strategy to support calcium and iron- folic acid supplementation among pregnant women in Ethiopia and Kenya. Matern Child Nutr. 2017; 13(3): e12331. https://doi.org/10.1111/mcn.12331 PMid: 27507135 PMCid: PMC6866070.
